Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Raskin

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
Journal of Diabetes and Its Complications|October 30, 2003
Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metforminCharles Kilo, Nicholas Mezitis, Rajeev Jain, et al.
Journal of Diabetes and Its Complications|April 25, 2006
Comparison of type 1, type 2, and atypical ketosis-prone diabetes at 4 years of diabetes durationMaría A Ramos-Román, Antonio Piñero-Piloña, Beverley Adams-Huet, et al.
Clinical Therapeutics|March 8, 2006
Efficacy of biphasic insulin aspart in patients with type 2 diabetesSerge Halimi, Philip Raskin, Andreas Liebl, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|February 27, 2014
Intensive therapy in newly diagnosed type 2 diabetes: results of a 6-year randomized trialLindsay B Harrison, Beverley Adams-Huet, Xilong Li, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 17, 2007
Insulin as initial therapy in type 2 diabetes: effective, safe, and well acceptedIldiko Lingvay, Polina F Kaloyanova, Beverley Adams-Huet, et al.
Hormones (Athens, Greece)|September 8, 2006
Postprandial glucose and its role in type 2 diabetes, Jaime Davidson, Stephen Gough, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 14, 2002
Anemia associated with new-onset diabetes: improvement with blood glucose controlAntonio Piñero-Piloña, Patrick Litonjua, Sridevi Devaraj, et al.
Circulation|February 27, 2008
Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and MetabolismPrakash Deedwania, Mikhail Kosiborod, Eugene Barrett, et al.
Anesthesiology|June 27, 2008
Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and MetabolismPrakash Deedwania, Mikhail Kosiborod, Eugene Barrett, et al.
Journal of the American Society of Nephrology : JASN|November 21, 2009
Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathyUzma F Mehdi, Beverley Adams-Huet, Philip Raskin, et al.
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Journal of Diabetes and Its Complications|October 30, 2003
Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metforminCharles Kilo, Nicholas Mezitis, Rajeev Jain, et al.
Journal of Diabetes and Its Complications|April 25, 2006
Comparison of type 1, type 2, and atypical ketosis-prone diabetes at 4 years of diabetes durationMaría A Ramos-Román, Antonio Piñero-Piloña, Beverley Adams-Huet, et al.
Clinical Therapeutics|March 8, 2006
Efficacy of biphasic insulin aspart in patients with type 2 diabetesSerge Halimi, Philip Raskin, Andreas Liebl, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|February 27, 2014
Intensive therapy in newly diagnosed type 2 diabetes: results of a 6-year randomized trialLindsay B Harrison, Beverley Adams-Huet, Xilong Li, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 17, 2007
Insulin as initial therapy in type 2 diabetes: effective, safe, and well acceptedIldiko Lingvay, Polina F Kaloyanova, Beverley Adams-Huet, et al.
Hormones (Athens, Greece)|September 8, 2006
Postprandial glucose and its role in type 2 diabetes, Jaime Davidson, Stephen Gough, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 14, 2002
Anemia associated with new-onset diabetes: improvement with blood glucose controlAntonio Piñero-Piloña, Patrick Litonjua, Sridevi Devaraj, et al.
Circulation|February 27, 2008
Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and MetabolismPrakash Deedwania, Mikhail Kosiborod, Eugene Barrett, et al.
Anesthesiology|June 27, 2008
Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and MetabolismPrakash Deedwania, Mikhail Kosiborod, Eugene Barrett, et al.
Journal of the American Society of Nephrology : JASN|November 21, 2009
Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathyUzma F Mehdi, Beverley Adams-Huet, Philip Raskin, et al.
Pageof 13